Tirzepatide has emerged as a groundbreaking medication for type 2 diabetes, offering promising outcomes. However, the expense of this innovative drug and its availability have become key concerns for patients and healthcare practitioners. While tirzepatide has been approved by regulatory agencies, its high-priced nature presents a significant barr